Patents by Inventor Inigo Saenz De Tejada-Gorman

Inigo Saenz De Tejada-Gorman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF 2,5-DIHYDROXYBENZENE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT OF PSORIASIS
    Publication number: 20110311528
    Abstract: The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, psoriasis.
    Type: Application
    Filed: June 22, 2011
    Publication date: December 22, 2011
    Applicant: Action Medicines
    Inventors: Pedro Cuevas Sánchez, Guillermo Gimenez Gallego, Inigo Saenz de Tejada Gorman, Javier Angulo Frutos, Serafin Valverde Lopez, Antonio Romero Garrido, Rosa Maria Lozano Puerto
  • Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases
    Publication number: 20080114063
    Abstract: The present invention relates to the use of a compound of Formula (I?) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of any of the diseases selected from the group consisting of benign prostatic hyperplasia, Barrett's disease, asthma, skeletal muscle and tendon repair, Crohn's disease, ulcerative colitis and leishmaniasis.
    Type: Application
    Filed: August 15, 2007
    Publication date: May 15, 2008
    Applicant: Action Medicines
    Inventors: Pedro Cuevas Sanchez, Guillermo Gimenez Gallego, Inigo Saenz de Tejada Gorman, Javier Angulo Frutos, Luis Ignacio Rivas Lopez, Francisco Javier Moreno Nuncio, Tomas Fernado Fernandez Jaen, Rosa Maria Lozano Puerto, Antonio Romero Garrido, Serafin Valverde Lopez
  • Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea
    Publication number: 20080113947
    Abstract: The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, rosacea.
    Type: Application
    Filed: August 15, 2007
    Publication date: May 15, 2008
    Applicant: Action Medicines
    Inventors: Pedro Cuevas Sanchez, Guillermo Gimenez Gallego, Inigo Saenz de Tejada Gorman, Javier Angulo Frutos, Serafin Valverde Lopez, Antonio Romero Garrido, Rosa Maria Lozano Puerto
  • Use of derivatives of 2, 5-dihydroxyb enzene-sulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile dysfunction
    Publication number: 20070197543
    Abstract: The present invention refers to the use of derivatives of 2,5-dihidroxybenzenosulphonic acids of general formula (I), to develop medicinal products of therapeutic value to enhance the effects of phosphodiesterase-5 including sildenaphyl, vardenaphyl and IC-351, of apomorphine, of nitric oxide donors including amyl nitrate, nitroglycerine, nitroprussiate, nitrosothioles and nicorandyl, of the compounds that increase the level of cyclic GMP in the penile tissue and of other compounds used to facilitate penile erection in man.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 23, 2007
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman
  • Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
    Publication number: 20070032471
    Abstract: The present invention relates to an active substance combination comprising at least one 2,5-dihydroxybenzenesulfonic compound and at least one K+ channel modulator, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 8, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Ines Alvarez Mathieu, Inigo Saenz De Tejada Gorman, Javier Angulo Frutos, Helmut-Heinrich Buschmann
  • Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
    Publication number: 20070010581
    Abstract: The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds for the manufacture of medicament for the regulation of nitric oxide (NO) synthesis and/or the regulation of EDHF (Endothelium-derived-Hyperpolarizing-Factor) in the endothelium of humans or animals, whereby the medicament is administered in a daily dose of the 2,5-dihydroxybenzenesulfonic compounds of formula I of <500 mg.
    Type: Application
    Filed: November 29, 2003
    Publication date: January 11, 2007
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman, Javier Angulo-Frutos
  • Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
    Publication number: 20060135611
    Abstract: The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds for the manufacture of a medicament for the regulation of nitric oxide (NO) synthesis and/or the regulation of EDHF (Endothelium-Derived-Hyperpolarizing-Factor) in the endothelium of diabetic patients, whereby the medicament is administered in a daily dose of the 2,5-dihydroxybenzenesulfonic compounds of formula (I) of <500 mg.
    Type: Application
    Filed: November 29, 2003
    Publication date: June 22, 2006
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman, Javier Angulo-Frutos
  • Use of derivatives of 2, 5-dihydroxybenzenesulphonic acid derivatives in the production of a medication used to potentiate the effect of other drugs in the treatment of erectile dysfunction
    Publication number: 20040143010
    Abstract: The present invention refers to the use of derivatives of 2,5-dihidroxybenzenosulphonic acids of general formula (I), to develop medicinal products of therapeutic value to enhance the effects of phosphodiesterase-5 including sildenaphyl, vardenaphyl and IC-351, of apomorphine, of nitric oxide donors including amyl nitrate, nitroglycerine, nitroprussiate, nitrosothioles and nicorandyl, of the compounds that increase the level of cyclic GMP in the penile tissue and of other compounds used to facilitate penile erection in man.
    Type: Application
    Filed: March 11, 2004
    Publication date: July 22, 2004
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman